You searched for "otology"
Andreas Wagner: ESPO 2025 keynote speaker
The keynote speaker for ESPO 2025 in Stuttgart is renowned evolutionary biologist and author Professor Andreas Wagner, from Zurich. Prof Wagner will focus on the congress theme of ‘Innovation’, giving us his unique perspective on how evolution drives human creativity....Andreas Wagner: ESPO 2025 keynote speaker
The keynote speaker for ESPO 2025 in Stuttgart is renowned evolutionary biologist and author Professor Andreas Wagner, from Zurich. Prof Wagner will focus on the congress theme of ‘Innovation’, giving us his unique perspective on how evolution drives human creativity....Inside the Larynx on Radio 3
Radio 3’s The Essay this week features Nicky Spence, operatic tenor and professor of voice, in conversation with our editor Declan Costello, ENT surgeon and one of Britain’s leading voice specialists.
Grading dysphagia as a toxicity in treating head and neck cancer
Common Terminology Criteria for Adverse Events (CTCAE) is a system used by clinicians to grade the toxicity of oncology treatments in a standardised manner. Dysphagia is perhaps the most common long-term toxicity of head and neck cancer treatment. Currently, a...Developing ENT services in Zambia
Lufunda Lukama and Matthew Clark. Lufunda Lukama is an ENT surgeon in Zambia. In a country of 19.6 million, he is one of five such specialists. It is not difficult to see the problem that he, and the country as...In conversation with Professor Gerry O’Donoghue
On the occasion of his retirement from the Nottingham Auditory Implant Programme, we discuss his pioneering work in cochlear implantation and the challenges involved. ENT News author picture, 1993. Why did you choose a career in ENT? I started off...The search for pharmacological treatments for hearing loss and tinnitus
Where are we in our search for a hearing restoration grail? Nicola Robas leads us through the map pieces discovered in creating a pharmaceutical answer to hearing loss and tinnitus. Together, hearing loss and tinnitus affect over one in six...Discovery in the genetics of complex disease: Otitis media
Otitis media (OM), a common disease of childhood, is considered to be a complex trait with multiple genetic and environmental factors expected to contribute to a child’s risk of developing recurrent acute OM (rAOM; ≥3 episodes in 6 months or...COOL therapy for cisplatin-induced hearing loss
Cisplatin is a commonly used cancer therapy, with nearly 50% of patients undergoing chemotherapy receiving cisplatin as part of their regimen [1]. Depending on the dose, incidence of hearing loss has been reported as 12-100% in adults, and 37-94% in...
